Vitrolife AB (VITR) Stock Statistics & Valuation Metrics

Vitrolife AB has a market cap or net worth of kr12.95B. The enterprise value is kr12.66B.

Vitrolife AB has 135,447,190 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vitrolife AB’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -45.82%.

The current PE Ratio of Vitrolife AB is ―. Vitrolife AB’s PEG ratio is 0.00344.

In the last 12 months, Vitrolife AB had revenue of 3.44B and earned -5.01B in profits. Earnings per share was -37.01.

In the last 12 months, operating cash flow was 727.00M and capital expenditures -114.00M, giving a free cash flow of 613.00M billion.

Vitrolife AB pays an annual dividend of kr1.1, resulting in a dividend yield of 1.15%

Vitrolife AB upcoming earnings date is Oct 22, 2026, Before Open (Confirmed).

Vitrolife AB as a current ratio of 3.40, with Debt / Equity ratio of 19.69%

In the past 12 months, Vitrolife AB has paid 127.00M in taxes.

Vitrolife AB EV to EBITDA ratio is -4.41, with an EV/FCF ratio of 42.06.

Vitrolife AB has kr823.00M in cash and marketable securities with kr1.60B in debt, giving a net cash position of -kr778.00M billion.

Gross margin is 59.26%, with operating margin of -140.55%, and net profit margin of -145.73%.

The average price target for Vitrolife AB is ―, which is 11.43% higher than the current price. The consensus rating is ―